TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ATH Stock 12 Month Forecast
Average Price Target
AU$0.02
▲(50.85% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Alterity Therapeutics in the last 3 months. The average price target is AU$0.02 with a high forecast of AU$0.02 and a low forecast of AU$0.02. The average price target represents a 50.85% change from the last price of AU$0.01.
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.
ATH Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
1
In the current month, ATH has received 1Buy Ratings, 0Hold Ratings, and 0Sell Ratings. ATH average Analyst price target in the past 3 months is 0.02.
Each month's total comprises the sum of three months' worth of ratings.
ATH Financial Forecast
ATH Earnings Forecast
Next quarter’s earnings estimate for ATH is >-AU$0.01 with a range of >-AU$0.01 to >-AU$0.01. The previous quarter’s EPS was >-AU$0.01. ATH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ATH has Performed in-line its overall industry.
Next quarter’s earnings estimate for ATH is >-AU$0.01 with a range of >-AU$0.01 to >-AU$0.01. The previous quarter’s EPS was >-AU$0.01. ATH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ATH has Performed in-line its overall industry.
No data currently available
ATH Sales Forecast
Next quarter’s sales forecast for ATH is AU$0.00 with a range of AU$0.00 to AU$0.00. The previous quarter’s sales results were AU$0.00. ATH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ATH has Performed in-line its overall industry.
Next quarter’s sales forecast for ATH is AU$0.00 with a range of AU$0.00 to AU$0.00. The previous quarter’s sales results were AU$0.00. ATH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ATH has Performed in-line its overall industry.
ATH Stock Forecast FAQ
What is AU:ATH’s average 12-month price target, according to analysts?
Based on analyst ratings, Alterity Therapeutics Ltd.’s 12-month average price target is 0.02.
What is AU:ATH’s upside potential, based on the analysts’ average price target?
Alterity Therapeutics Ltd. has 50.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Alterity Therapeutics Ltd. a Buy, Sell or Hold?
Alterity Therapeutics Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Alterity Therapeutics Ltd.’s share price target?
The average share price target for Alterity Therapeutics Ltd. is 0.02. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is AU$0.02 ,and the lowest forecast is AU$0.02. The average share price target represents 50.85% Increase from the current price of <AU$0.1.
What do analysts say about Alterity Therapeutics Ltd.?
Alterity Therapeutics Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Alterity Therapeutics Ltd.?
To buy shares of AU:ATH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.